Profile data is unavailable for this security.
About the company
Shanghai Haohai Biological Technology Co., Ltd. is a China-based company principally engaged in biological technology-related businesses. The businesses of the Company include the manufacture and sales of biological and medical hyaluronate, the research and development of biological engineering and pharmaceutical products and the provision of related services. Its products include orthopedics products, medical aesthetics and wound care products, ophthalmology products and anti-adhesion and hemostasis products, among others. Orthopedics products include sodium hyaluronate injection, medical chitosan and medical sodium hyaluronate gel. Medical aesthetics and wound care products include recombinant human epidermal growth factor (rhEGF), among others. Ophthalmology products include ophthalmic viscoelastic devices and lubricant eye drops. Anti-adhesion and hemostasis products include medical collagen sponges, among others. The Company mainly operates businesses in Mainland China.
- Revenue in CNY (TTM)2.75bn
- Net income in CNY430.21m
- Incorporated2007
- Employees2.16k
- LocationShanghai Haohai Biological Technology Co Ltd4F, No 2 Building, Alley 139Anshun Road, Changning DistrictSHANGHAI 200336ChinaCHN
- Phone+86 2 152293555
- Fax+86 2 152293558
- Websitehttps://www.3healthcare.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shinva Medical Instrument Co Ltd | 10.12bn | 692.34m | 11.17bn | 8.21k | 13.03 | 1.49 | -- | 1.10 | 1.41 | 1.41 | 18.31 | 12.34 | 0.6775 | 2.20 | 4.96 | 1,232,589.00 | 4.72 | 4.63 | 9.14 | 10.76 | 25.62 | 24.22 | 6.96 | 6.12 | 0.8303 | -- | 0.1637 | 15.91 | 7.87 | -0.5342 | 30.78 | 95.70 | -5.90 | 61.86 |
| Qingdao Haier Biomedical Co Ltd | 2.24bn | 358.01m | 11.43bn | 2.64k | 31.90 | 2.66 | -- | 5.11 | 1.13 | 1.13 | 7.04 | 13.53 | 0.4018 | 5.12 | 6.38 | 848,473.70 | 6.56 | 11.49 | 8.29 | 15.22 | 47.82 | 49.98 | 16.34 | 25.20 | 2.53 | -- | 0.0316 | 26.53 | -20.36 | 22.07 | -32.41 | 28.94 | 20.64 | -- |
| Shandong Weigao Orthopaedic Devce Co Ltd | 1.28bn | 154.60m | 11.60bn | 2.21k | 75.16 | 2.96 | -- | 9.03 | 0.3858 | 0.3858 | 3.20 | 9.78 | 0.2524 | 0.6714 | 4.03 | 581,131.60 | 3.14 | 10.97 | 3.95 | 13.69 | 62.40 | 77.33 | 12.43 | 27.08 | 3.62 | -- | 0.0096 | 17.90 | -30.55 | 1.17 | -79.36 | -19.11 | -4.31 | -- |
| Shanghai Runda Medical Technology Co Ltd | 8.43bn | 40.27m | 12.13bn | 3.32k | 300.95 | 2.83 | -- | 1.44 | 0.0673 | 0.0673 | 13.61 | 7.17 | 0.5831 | 4.19 | 1.49 | 2,543,990.00 | 1.18 | 4.78 | 3.13 | 12.86 | 25.94 | 27.13 | 2.03 | 6.36 | 1.01 | 3.04 | 0.5609 | 12.43 | -12.84 | 8.93 | -34.58 | 0.8514 | 3.88 | 1.03 |
| Beijing Wandong Medical Technolgy Co Ltd | 1.40bn | 184.09m | 12.18bn | 1.06k | 66.10 | 2.57 | -- | 8.67 | 0.262 | 0.262 | 2.00 | 6.74 | 0.2647 | 2.76 | 4.01 | 1,325,746.00 | 3.50 | 5.30 | 3.91 | 6.21 | 38.83 | 45.21 | 13.22 | 16.46 | 9.48 | -- | 0.0179 | 35.82 | 10.30 | 5.32 | 7.51 | 4.22 | -16.66 | 5.39 |
| Shanghai MicroPort Edvcl MdTch Grp CoLtd | 1.27bn | 657.34m | 13.42bn | 908.00 | 20.01 | 3.45 | -- | 10.58 | 5.44 | 5.44 | 10.59 | 31.54 | 0.371 | 1.33 | 6.51 | 1,396,816.00 | 19.00 | 17.68 | 21.55 | 19.43 | 74.51 | 76.60 | 51.21 | 42.25 | 5.49 | -- | 0.0067 | 44.46 | 32.43 | 38.72 | 37.98 | 40.28 | 50.18 | -- |
| Micro-Tech Nanjing Co Ltd | 2.68bn | 550.49m | 13.96bn | 2.40k | 25.28 | 3.74 | -- | 5.21 | 2.94 | 2.94 | 14.30 | 19.86 | 0.6118 | 1.65 | 6.80 | 1,114,222.00 | 12.87 | 10.74 | 15.26 | 12.82 | 66.04 | 63.04 | 21.04 | 19.37 | 3.99 | -- | 0.0183 | 35.43 | 21.78 | 21.20 | 46.99 | 20.32 | 39.33 | -- |
| Shanghai Haohai Biological Tech Co Ltd | 2.75bn | 430.21m | 13.98bn | 2.16k | 35.73 | 2.76 | -- | 5.09 | 1.86 | 1.86 | 11.89 | 24.07 | 0.3833 | 1.60 | 7.60 | 1,272,966.00 | 5.60 | 4.84 | 6.60 | 5.50 | 68.97 | 72.04 | 14.61 | 16.36 | 3.71 | -- | 0.0697 | 36.86 | 24.59 | 11.24 | 130.58 | 0.0762 | 11.96 | -- |
| Sansure Biotech Inc | 1.41bn | 259.42m | 14.05bn | 2.01k | 53.92 | 1.91 | -- | 9.99 | 0.4475 | 0.4475 | 2.44 | 12.62 | 0.1667 | 0.878 | 2.03 | 701,473.70 | 2.52 | 26.74 | 2.79 | 30.97 | 76.43 | 67.47 | 15.12 | 42.01 | 7.45 | -- | 0.0583 | 22.40 | -84.39 | 27.12 | -81.22 | 121.89 | 64.08 | -- |
| iRay Technology Co Ltd | 1.82bn | 564.72m | 16.71bn | 1.66k | 31.27 | 3.64 | -- | 9.16 | 3.74 | 3.74 | 12.14 | 32.15 | 0.2544 | 1.03 | 2.56 | 1,097,588.00 | 7.81 | 12.07 | 8.48 | 13.86 | 53.92 | 55.59 | 30.71 | 34.51 | 4.23 | -- | 0.3972 | 31.52 | 20.31 | 33.51 | -5.27 | 58.58 | 107.96 | -- |
Data as of Sep 13 2024. Currency figures normalised to Shanghai Haohai Biological Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
3.81%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Hwabao WP Fund Management Co., Ltd.as of 30 Jun 2024 | 2.48m | 1.28% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2024 | 1.49m | 0.77% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 689.77k | 0.36% |
| The Vanguard Group, Inc.as of 06 Nov 2024 | 545.33k | 0.28% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 492.15k | 0.25% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2024 | 424.91k | 0.22% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 356.17k | 0.18% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 330.19k | 0.17% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 310.14k | 0.16% |
| Yinhua Fund Management Co., Ltd.as of 30 Jun 2024 | 272.89k | 0.14% |
More ▼
Data from 30 Jun 2024 - 11 Nov 2024Source: FactSet Research Systems Inc.
